Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03865264 · ClinicalTrials.gov registry record · NA
Living Organ Donor Recovery Enhancement Program
A NA study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03865264: Clinical Trial NA study, sponsored by Baylor Research Institute.
NCT03865264 is a NA study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03865264, a NA study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of the study is to test if using these living donor-specific pre-transplant resources would lead to a better and faster recovery post-transplant.
Primary Outcome
Pre-operative emotional stress
Interventions
- OTHER Recovery Enhancement Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-04-20 |
| Est. Completion | 2024-01-22 |
| Phase | NA |
Why NCT03865264 stopped before completion
NCT03865264 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Recovery Enhancement Program is the first listed.
NCT03865264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03865264 about?
NCT03865264 is a clinical study titled "Living Organ Donor Recovery Enhancement Program". The purpose of the study is to test if using these living donor-specific pre-transplant resources would lead to a better and faster recovery post-transplant.
What is the current status of trial NCT03865264?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2017-04-20. Estimated completion is 2024-01-22.
What interventions are being tested in trial NCT03865264?
The interventions under investigation include: Recovery Enhancement Program (OTHER).
Who is sponsoring clinical trial NCT03865264?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03865264's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI